View in EDS

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

Saved in:
Bibliographic Details
Title: Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
Authors: Lang, I.1 lang@oncol.hu, Inbar, M.J.2, Kahán, Z.3, Greil, R.4, Beslija, S.5, Stemmer, S.M.6, Kaufman, B.7, Zvirbule, Z.8, Steger, G.G.9, Messinger, D.10, Brodowicz, T.9,11, Zielinski, C.9,11
Source: European Journal of Cancer. Nov2012, Vol. 48 Issue 17, p3140-3149. 10p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 83186720
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lang%2C+I%2E%22">Lang, I.</searchLink><relatesTo>1</relatesTo><i> lang@oncol.hu</i><br /><searchLink fieldCode="AR" term="%22Inbar%2C+M%2EJ%2E%22">Inbar, M.J.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kahán%2C+Z%2E%22">Kahán, Z.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Greil%2C+R%2E%22">Greil, R.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Beslija%2C+S%2E%22">Beslija, S.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Stemmer%2C+S%2EM%2E%22">Stemmer, S.M.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kaufman%2C+B%2E%22">Kaufman, B.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Zvirbule%2C+Z%2E%22">Zvirbule, Z.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Steger%2C+G%2EG%2E%22">Steger, G.G.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Messinger%2C+D%2E%22">Messinger, D.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Brodowicz%2C+T%2E%22">Brodowicz, T.</searchLink><relatesTo>9,11</relatesTo><br /><searchLink fieldCode="AR" term="%22Zielinski%2C+C%2E%22">Zielinski, C.</searchLink><relatesTo>9,11</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Nov2012, Vol. 48 Issue 17, p3140-3149. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=83186720
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2012.04.022
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 3140
    Titles:
      – TitleFull: Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lang, I.
      – PersonEntity:
          Name:
            NameFull: Inbar, M.J.
      – PersonEntity:
          Name:
            NameFull: Kahán, Z.
      – PersonEntity:
          Name:
            NameFull: Greil, R.
      – PersonEntity:
          Name:
            NameFull: Beslija, S.
      – PersonEntity:
          Name:
            NameFull: Stemmer, S.M.
      – PersonEntity:
          Name:
            NameFull: Kaufman, B.
      – PersonEntity:
          Name:
            NameFull: Zvirbule, Z.
      – PersonEntity:
          Name:
            NameFull: Steger, G.G.
      – PersonEntity:
          Name:
            NameFull: Messinger, D.
      – PersonEntity:
          Name:
            NameFull: Brodowicz, T.
      – PersonEntity:
          Name:
            NameFull: Zielinski, C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: Nov2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 09598049
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: European Journal of Cancer
              Type: main
ResultId 1